SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-14-001306
Filing Date
2014-04-30
Accepted
2014-04-30 16:33:12
Documents
3
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K form10k-a.htm 10-K/A 348755
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 12786
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 12597
  Complete submission text file 0001493152-14-001306.txt   375375
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35814 | Film No.: 14799318
SIC: 2834 Pharmaceutical Preparations